시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
전기생리학 기기 시장 보고서 : 제품, 적응증, 최종사용자, 지역별(2025-2033년)
Electrophysiology Devices Market Report by Product, Indication (Atrial Fibrillation, Supraventricular Tachycardia, Atrioventricular Nodal Re-entry Tachycardia, Wolff-Parkinson-White Syndrome, Bradycardia, and Other), End User, and Region 2025-2033
상품코드 : 1800893
리서치사 : IMARC
발행일 : 2025년 08월
페이지 정보 : 영문 148 Pages
 라이선스 & 가격 (부가세 별도)
US $ 2,999 ￦ 4,337,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트 등의 Copy&Paste도 불가능합니다.
US $ 3,999 ￦ 5,783,000
PDF & Excel (5 User License) help
PDF & Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 불가능합니다. 인쇄는 5부까지 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,999 ￦ 7,230,000
PDF & Excel (Corporate License) help
PDF & Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy&Paste가 불가능합니다. 인쇄는 5부까지 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

세계 전기생리학 기기 시장 규모는 2024년 67억 달러에 달했습니다. IMARC Group은 2033년까지 시장 규모가 129억 달러에 달하고, 2025-2033년 7.58%의 연평균 성장률(CAGR)을 보일 것으로 예측했습니다. 부정맥 사례 증가, 기술 발전, 저침습적 시술에 대한 수요 증가, 의료비 증가, 외래 치료 환경 확대, 유리한 상환 정책, 조기 진단에 대한 인식 증가, 의료기기에 인공지능(AI) 통합 등이 시장 성장을 가속하는 요인으로 작용하고 있습니다.

전기생리학 기기 시장 동향 :

심장 부정맥의 유병률 증가

심방세동(AF) 및 기타 다양한 악성 질환과 같은 심장 부정맥의 유병률 증가가 시장 성장의 원동력이 되고 있습니다. 업계 보고서에 따르면, 심방세동(AF)은 심장의 전기적 또는 신호/플러터 문제로 알려져 있으며, 미국에서 약 270만 명이 앓고 있다고 합니다. 심방세동은 뇌졸중과 심부전의 가장 흔한 원인으로 의료서비스에 대한 부담이 증가하고 있습니다. 또한, 기술의 발전과 가처분 소득 증가로 부정맥에 대한 환자들의 인식이 높아지면서 조기 진단 및 조기 치료가 요구되고 있습니다.

전기 생리학 장치의 기술 발전

전기 생리학 장치 시장의 성장은 주로 급속한 기술 발전에 의해 뒷받침되고 있습니다. 3D 매핑 시스템 및 기타 기술 혁신을 통해 심장 전문의는 심장의 전기적 활동의 특정 모델을 설계할 수 있게 되어 부정맥 환자의 진단과 치료를 개선할 수 있습니다. 또한, 카테터 절제술 기술의 발전은 시술의 위험을 줄이고, 환자의 회복 시간을 최소화하며, 성공률을 높이는 데 도움이 되고 있습니다. 이에 따라 전기 생리학에서 로봇 보조 시스템의 사용은 수술 중 정확도와 제어를 향상시켜 시장 성장을 크게 촉진하고 있습니다.

저침습적 시술의 성장

최소침습(MI) 전기생리학적 시술은 회복 시간, 입원 기간, 시술 위험을 줄일 수 있어 환자 치료에 큰 수요를 불러일으키고 있습니다. 부정맥 치료에 사용되는 카테터 절제술과 같은 시술은 표준 수술의 대안으로 보다 덜 외상적인 대안을 제공합니다. 이를 통해 더욱 정확한 진단이 가능해져 환자의 수술 비용과 부담을 줄이면서 치료 결과를 높일 수 있습니다. 이와는 별도로, 이미징 및 매핑 기술의 개발은 MI 개입을 더 번거롭게 만들지 않고 시장 성장을 가속하고 있습니다.

목차

제1장 서문

제2장 조사 범위와 조사 방법

제3장 주요 요약

제4장 서론

제5장 세계의 전기생리학 기기 시장

제6장 시장 분석 : 제품별

제7장 시장 분석 : 적응증별

제8장 시장 분석 : 최종사용자별

제9장 시장 분석 : 지역별

제10장 SWOT 분석

제11장 밸류체인 분석

제12장 Porter의 Five Forces 분석

제13장 가격 분석

제14장 경쟁 구도

LSH
영문 목차

영문목차

The global electrophysiology devices market size reached USD 6.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.9 Billion by 2033, exhibiting a growth rate (CAGR) of 7.58% during 2025-2033. Rising cardiac arrhythmia cases, technological advancements, growing demand for minimally invasive procedures, increasing healthcare expenditure, expanding outpatient care settings, favorable reimbursement policies, escalating awareness of early diagnosis, and the integration of artificial intelligence (AI) in medical devices are some of the factors driving the market growth.

Electrophysiology Devices Market Trends:

Rising Prevalence of Cardiac Arrhythmias

Increasing prevalence of cardiac arrhythmias such as atrial fibrillation (AF) and various other malignant are driving the market growth. According to the industry reports, atrial fibrillation (AF), known as the electrical or signaling/flutter problem in the heart, is affecting almost 2.7 million people in United States. AF is the most common cause of strokes and heart failure, which is creating a growing burden on health services. In addition, expanding technological advancements and disposable income has boosted awareness about arrhythmias among patients, due to which they prefer early diagnosis and treatment.

Technological Advancements in Electrophysiology Devices

The growth of the electrophysiology devices market is primarily bolstered by the rapid technological advancements. 3D mapping systems and other innovations enable cardiologists to design specified models of the heart's electrical activity, which improves diagnosis and treatment for patients suffering with arrhythmias. Additionally, the improvements in catheter ablation technologies helps reduce procedural risks, while minimizing patient recovery times and increasing success rates. In line with this, the use of robotic-assisted systems in electrophysiology has also improved the precision and control during procedures, which is providing a considerable boost to the market growth.

Growth of Minimally Invasive Procedures

Minimally invasive (MI) electrophysiology procedures can reduce recovery times, hospital stays, and procedural risks, which is why they are witnessing a considerable demand for the treatment of patients. Procedures such as catheter ablation, which are used to treat arrhythmias, provide a less traumatic alternative to the standard surgeries. This further enables an accurate diagnosis and enhances the results of treatment at a reduced cost and strain of surgeries on patients. Apart from this, the development of imaging and mapping technologies, in turn, has made MI interventions less cumbersome, which is facilitating the market growth.

Electrophysiology Devices Market Segmentation:

Breakup by Product:

Diagnostic devices accounts for the majority of the market share

The diagnostic devices segment is driven by the increasing prevalence of cardiovascular diseases, particularly arrhythmias, which require precise diagnosis for effective treatment. Technological advancements, such as improved electrocardiographs (ECGs) and EP mapping systems, are enhancing diagnostic accuracy, leading to wider adoption of these devices. Additionally, the growing awareness of early detection and prevention of heart conditions is boosting demand for diagnostic tools like Holter monitors and insertable cardiac monitors (ICMs). Healthcare providers are increasingly relying on these devices for continuous monitoring and accurate data collection, which improves patient outcomes. The rise in minimally invasive diagnostic procedures, which offer quicker recovery times and reduce the need for hospital stays, is further contributing to the segment's growth.

Breakup by Indication:

Atrial fibrillation (AF) holds the largest share of the industry

The atrial fibrillation (AF) segment is driven by the increasing global prevalence of AF, particularly among aging populations, which is a leading cause of stroke and heart failure. As awareness about AF grows, there is a rising demand for early diagnosis and effective treatment, prompting healthcare providers to invest in advanced electrophysiology devices. Technological advancements in diagnostic tools, such as 3D mapping systems and catheter ablation technologies, have improved the accuracy of AF detection and treatment success rates, boosting adoption. Additionally, the growing preference for minimally invasive procedures, which offer faster recovery times and reduced complications, is further accelerating demand for electrophysiology devices in AF management.

Breakup by End User:

Hospitals represents the leading market segment

The hospital segment is driven by the increasing prevalence of cardiovascular diseases, particularly arrhythmias, which require specialized electrophysiology procedures. Hospitals are equipped with advanced technology, such as 3D mapping and catheter ablation systems, enabling them to offer comprehensive cardiac care. The growing demand for minimally invasive procedures, which are often performed in hospital settings, further fuels this segment. Additionally, hospitals have skilled healthcare professionals capable of handling complex electrophysiology treatments, which boosts patient confidence in seeking care at these facilities. Rising healthcare expenditure, particularly in developed regions, allows hospitals to invest in cutting-edge electrophysiology devices, enhancing their capabilities.

Breakup by Region:

North America leads the market, accounting for the largest electrophysiology devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for electrophysiology devices.

As per the electrophysiology devices market dynamics, the North America's regional market is driven by the increasing prevalence of cardiovascular diseases, particularly atrial fibrillation, among the aging population. Advanced healthcare infrastructure and widespread access to cutting-edge medical technologies support the adoption of electrophysiology devices across the region. Rising awareness of early diagnosis and treatment of heart conditions is boosting demand for these devices. Additionally, the growing preference for minimally invasive procedures has increased the use of catheter ablation and other electrophysiology tools. Continuous advancements in medical technology, such as 3D mapping systems and artificial intelligence (AI) integration, enhance the accuracy and outcomes of procedures, making them more attractive to both patients and healthcare providers, which is further driving the electrophysiology devices demand.

Competitive Landscape:

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Electrophysiology Devices Market

6 Market Breakup by Product

7 Market Breakup by Indication

8 Market Breakup by End User

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기